Explore how Rentschler Biopharma accelerated process development, scaled manufacturing, and streamlined PPQ to help a client beat the competition and become first to market.
As the biopharma industry grows more and more competitive each year, strategic partnerships are critical to gain a competitive advantage — and help novel therapies reach the patients that need them most.
After a client faced direct competition in developing a novel therapy analogous to one in development at a rival pharmaceutical company, Rentschler Biopharma successfully expedited the project from the initial good manufacturing practice (cGMP) manufacturing run through to PPQ in a record 12 months, showcasing its capability to meet and exceed the demanding industry standards.
In this Playbook, you’ll learn how Rentschler Biopharma:
- Leveraged its global expertise to streamline and expedite process development and PPQ
- Developed robust, scalable processes to support commercialization
- Applied the “secrets to success” that allowed a client to condense GMP to PPQ development into 12 months — and beat rival companies to become first to market
Offered Free by: BioPharma Dive’s studioID and Rentschler
See All Resources from: BioPharma Dive’s studioID and Rentschler
